Quantitative proteomic Isotope-Coded Protein Label (ICPL) analysis reveals alteration of several functional processes in the glioblastoma

被引:37
作者
Com, Emmanuelle [1 ]
Clavreul, Anne [2 ]
Lagarrigue, Melanie [1 ]
Michalak, Sophie [3 ]
Menei, Philippe [2 ]
Pineau, Charles [1 ]
机构
[1] Inserm U1085, IRSET, Prote Core Facil Biogenouest, F-35042 Rennes, France
[2] CHU Angers, Inserm U646, F-49933 Angers 09, France
[3] CHU Angers, Dept Pathol Cellulaire & Tissulaire, F-49933 Angers 09, France
关键词
Proteome; Glioblastoma; Cancer; ICPL; HEAT-SHOCK PROTEINS; MALIGNANT GLIOMAS; SODIUM-PUMP; EXPRESSION; CANCER; CELLS; IDENTIFICATION; RECURRENCE; STRATEGIES; RESISTANCE;
D O I
10.1016/j.jprot.2012.04.034
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Glioblastoma (GB), the most frequent primary tumor of the central nervous system, remains one of the most lethal human cancers despite intensive researches. Current paradigm in the study of GB has been focused on inter-patient variability and on trying to isolate new classification elements or prognostic factors. Here, using ICPL, a technique for protein relative quantification by mass spectrometry, we investigated protein expression between the four regions of GB on clinically relevant biopsies from 5 patients. We identified 584 non-redundant proteins and 31 proteins were found to be up-regulated in the tumor region compared to the peri-tumoral brain tissue, among which, 24 proteins belong to an interaction network linked to 4 biological processes. The core of this network is mainly constituted of interactions between beta-actin (ACTB) with heat shock proteins (HSP90AA1, HSPA8) and 14-3-3 proteins (YWHAZ, YWHAG, YWHAB). A cluster of three isoforms of the sodium pump a-subunit (ATP1A1, ATP1A2, ATP1A3) was also identified outside this network. The differential expression observed for ACTB and 14-3-3 gamma was further validated by western blot and/or immunohistochemistry. Our study confirms the identity of previously proposed molecular targets, highlights several functional processes altered in GB such as energy metabolism and synaptic transmission and could thus provide added value to new therapeutic trails. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:3898 / 3913
页数:16
相关论文
共 49 条
[11]   Glioma Pathophysiology: Insights Emerging from Proteomics [J].
Deighton, Ruth F. ;
McGregor, Richard ;
Kemp, Jocelyn ;
McCulloch, James ;
Whittle, Ian R. .
BRAIN PATHOLOGY, 2010, 20 (04) :691-703
[12]   Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma [J].
Giese, A ;
Kucinski, T ;
Knopp, U ;
Goldbrunner, R ;
Hamel, W ;
Mehdorn, HM ;
Tonn, JC ;
Hilt, D ;
Westphal, M .
JOURNAL OF NEURO-ONCOLOGY, 2004, 66 (03) :351-360
[13]   Identification of secreted proteins regulated by cAMP in glioblastoma cells using glycopeptide capture and label-free quantification [J].
Hill, Jennifer J. ;
Moreno, Maria J. ;
Lam, Jean C. Y. ;
Haqqani, Arsalan S. ;
Kelly, John F. .
PROTEOMICS, 2009, 9 (03) :535-549
[14]   Magnetic resonance image-guided proteomics of human glioblastoma multiforme [J].
Hobbs, SK ;
Shi, GY ;
Homer, R ;
Harsh, G ;
Atlas, SW ;
Bednarski, MD .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2003, 18 (05) :530-536
[15]  
Iacob Gabriel, 2009, J Med Life, V2, P386
[16]  
Kellermann Josef, 2008, V424, P113, DOI 10.1007/978-1-60327-064-9_10
[17]   The International Protein Index: An integrated database for proteomics experiments [J].
Kersey, PJ ;
Duarte, J ;
Williams, A ;
Karavidopoulou, Y ;
Birney, E ;
Apweiler, R .
PROTEOMICS, 2004, 4 (07) :1985-1988
[18]   Biomarker discovery: A proteomic approach for brain cancer profiling [J].
Khalil, Ashraf A. ;
James, Peter .
CANCER SCIENCE, 2007, 98 (02) :201-213
[19]   Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets? [J].
Khalil, Ashraf A. ;
Kabapy, Nihal F. ;
Deraz, Sahar F. ;
Smith, Christopher .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2011, 1816 (02) :89-104
[20]   Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis [J].
Lefranc, F ;
Brotchi, J ;
Kiss, R .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2411-2422